Recently Identified Immune Cells Possible Therapeutic Target for Eczema

News   Feb 06, 2013

 
Recently Identified Immune Cells Possible Therapeutic Target for Eczema
 
 
 

RELATED ARTICLES

BIA Separations appoints Pete Gagnon as Chief Scientific Officer

News

Appointment will drive new product and applications development.

READ MORE

Being Born During a Flu Pandemic May Increase Your Risk of Death During Another Flu Pandemic

News

While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, researchers are calling for more attention to exceptions to that rule.

READ MORE

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE